The company plans to unblind the late-stage study that was halted due to safety concerns, which could lead to an overhaul of its entire development program.
FDA hold puts Aardvark Prader-Willi drug in limbo
HOT NEWS
What Claims Data Misses: Finding Opportunity at the Point of…
Claims data reflects what already happened. Brand growth happens at the point of care. Commercial…
تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire Provides Press Release Distribution in Arabic
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…